Back to Search Start Over

Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC).

Authors :
Lowes S
Boterman M
Doig M
Breda M
Jersey J
Lelacheur R
Shoup R
Garofolo F
Dumont I
Martinez S
Needham S
Zimmer J
Caturla MC
Couerbe P
Maltas J
Steffen R
Petrilla J
Safavi A
Awaiye K
Bhatti M
Sheldon C
Schiebl C
Struwe P
Turk D
Sangster T
Pattison C
Fast D
Goodwin L
Kamerud J
Dinan A
Mamelak D
Islam R
Segers R
Lin ZJ
Hillier J
Garofolo W
Folguera L
Zimmer D
Zimmermann T
Pawula M
Moussallie M
de Souza Teixeira L
Rocha T
Allinson J
Jardieu P
Tang D
Gouty D
Wright L
Truog J
Lin J
Yamashita Y
Khan M
Liu Y
Xu A
Lundberg R
Cox C
Breau A
Hayes R
Bigogno C
Schoutsen D
Dilger C
Jonker J
Bouhajib M
Levesque A
Gagnon-Carignan S
Harman J
Nicholson R
Jenkins R
Warren M
Lin MH
Karnik S
De Boer T
Houghton R
Green R
Demaio W
Sable R
Smith K
Siethoff C
Cojocaru L
Allen M
Reuschel S
Gonzalez P
Harter T
Fatmi S
Rock M
Vija J
Sayyarpour F
Malone M
Nowatzke W
Best S
Fang X
Source :
Bioanalysis [Bioanalysis] 2012 Sep; Vol. 4 (17), pp. 2117-26.
Publication Year :
2012

Abstract

An open letter written by the Global CRO Council for Bioanalysis (GCC) describing the GCC survey results on stability data from co-administered and co-formulated drugs was sent to multiple regulatory authorities on 14 December 2011. This letter and further discussions at different GCC meetings led to subsequent recommendations on this topic of widespread interest within the bioanalytical community over the past 2 years.

Details

Language :
English
ISSN :
1757-6199
Volume :
4
Issue :
17
Database :
MEDLINE
Journal :
Bioanalysis
Publication Type :
Academic Journal
Accession number :
23013394
Full Text :
https://doi.org/10.4155/bio.12.192